EUVIMEDEUVIMED entdecken
Crossref

In vitro susceptibilities of fungal isolates against amphotericin B and voriconazole in Aspergillus keratitis: A comparative study

Gita Satpathy, Niranjan Nayak, Sujata Prasad, RavinderMohan Pandey, Namrata Sharma, Bhavna Chawla, JeewanS Tityal, Radhika Tandon

Journal of Clinical Ophthalmology and Research · 2013

DOI: 10.4103/2320-3897.112175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Ophthalmology and Research, 2013. Verfasst von Gita Satpathy und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To study the susceptibility patterns of clinical isolates of Aspergillus species to amphotericin B and voriconazole. Materials and Methods: Fifty isolates of Aspergillus species (21 A. flavus, 14 A. fumigatus and 15 A. niger) from keratitis cases were tested for their susceptibilities to amphotericin B and voriconazole by a broth microdilution method, standardized in our laboratory. The relative MIC 50 units were calculated from the absolute MIC 50 (μg/ml) upon topical prescription dose in gm/100 ml.

Results

The MIC values of amphotericin B for A. fumigatus and A. niger ranged between 0.2 mg/L to 6.25 mg/L (MIC 50; 1.56 mg/L and MIC 90; 6.25 mg/L) and for A. flavus between 0.78-6.25 mg/L (MIC 50 and MIC 90; 6.25 mg/L). MICs of voriconazole for A. fumigatus were in the ranges of 0.1 to 0.2 mg/L, for A. niger 0.05 to 0.2 mg/L (MIC 50 and MIC 90; 0.2 mg/L for both fungi) and against A. flavus 0.05 to 0.39 mg/L (MIC 50 ; 0.2 mg/L and MIC 90 ; 0.39 mg/L). The relative MIC 50 of voriconazole against all the three Aspergillus species was 0.002, compared to those of amphotericin B which were 0.104 against A. fumigatus and A. niger and 0.416 against A. flavus.

Conclusion

Voriconazole had lower MIC values and relative MICs than amphotericin B against Aspergillus species, the commonest fungi causing keratitis in this part of the country. Combined with its reported higher bio-availability, it appears far superior to amphotericin B for the treatment of fungal keratitis.

Zitieren

APA

Satpathy, G., Nayak, N., Prasad, S., Pandey, R., Sharma, N., Chawla, B., Tityal, J., & Tandon, R. (2013). In vitro susceptibilities of fungal isolates against amphotericin B and voriconazole in Aspergillus keratitis: A comparative study. Journal of Clinical Ophthalmology and Research. https://doi.org/10.4103/2320-3897.112175

Vancouver

Satpathy G, Nayak N, Prasad S, Pandey R, Sharma N, Chawla B, et al. In vitro susceptibilities of fungal isolates against amphotericin B and voriconazole in Aspergillus keratitis: A comparative study. Journal of Clinical Ophthalmology and Research. 2013. doi:10.4103/2320-3897.112175

BibTeX
@article{Satpathy2013,
  author = {Satpathy, Gita and Nayak, Niranjan and Prasad, Sujata and Pandey, RavinderMohan and Sharma, Namrata and Chawla, Bhavna and Tityal, JeewanS and Tandon, Radhika},
  title = {In vitro susceptibilities of fungal isolates against amphotericin B and voriconazole in Aspergillus keratitis: A comparative study},
  journal = {Journal of Clinical Ophthalmology and Research},
  year = {2013},
  doi = {10.4103/2320-3897.112175}
}
Kostenlos starten →